Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
26.16
-0.58 (-2.17%)
Nov 6, 2026, 4:00 PM EST - Market closed
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $5.43 billion as of November 6, 2026. It is the 3,299th most valuable company in the world and the 1,070th biggest in the United States. Its market cap has increased by 35.80% in one year.
Market Cap
5.43B
Enterprise Value
5.63B
1-Year Change
35.80%
Global Rank
Country Rank
#1,070 United States
Category
ChartMarket Cap Chart
Since December 29, 2014, Supernus Pharmaceuticals's market cap has increased from $1.53B to $5.43B, an increase of 255.04%. That is a compound annual growth rate of 11.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 5.43B | 21.30% |
| Dec 31, 2025 | 4.48B | 188.39% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elanco Animal Health | 11.83B |
| Dr. Reddy's Laboratories | 11.81B |
| Alkermes | 7.49B |
| Kiniksa Pharmaceuticals International, | 6.94B |
| Amneal Pharmaceuticals | 6.77B |
| Lantheus Holdings | 6.58B |
| Hims & Hers Health | 5.61B |
| Liquidia | 3.98B |